These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1509712)

  • 21. [Hyperinsulinism--a new pathogenic cause of cardiovascular diseases].
    Kúseková M; Sasinka M
    Cesk Pediatr; 1993 Mar; 48(3):136-40. PubMed ID: 8495516
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of Type II diabetes mellitus and insulin resistance in parents of women with polycystic ovary syndrome.
    Sir-Petermann T; Angel B; Maliqueo M; Carvajal F; Santos JL; Pérez-Bravo F
    Diabetologia; 2002 Jul; 45(7):959-64. PubMed ID: 12136394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Reaven's metabolic syndrome X in the families of individuals with premature cerebrovascular attacks].
    Vaverková H; Ficker L; Vlachová I; Chudácková J; Novotný D; Budíková M
    Vnitr Lek; 1993 Aug; 39(8):745-54. PubMed ID: 8212622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Role of abdominal obesity in pathogenesis of insulin resistance syndrome].
    Almazov VA; Blagosklonnaia IaV; Shliakhto EV; Krasil'nikova EI
    Ter Arkh; 1999; 71(10):18-22. PubMed ID: 10612167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prediction of cardiovascular and total mortality in Chinese type 2 diabetic patients by the WHO definition for the metabolic syndrome.
    Ko GT; So WY; Chan NN; Chan WB; Tong PC; Li J; Yeung V; Chow CC; Ozaki R; Ma RC; Cockram CS; Chan JC
    Diabetes Obes Metab; 2006 Jan; 8(1):94-104. PubMed ID: 16367887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
    Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
    Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of insulin resistance on risk of type 2 diabetes and cardiovascular disease in people with metabolic syndrome.
    Meigs JB; Rutter MK; Sullivan LM; Fox CS; D'Agostino RB; Wilson PW
    Diabetes Care; 2007 May; 30(5):1219-25. PubMed ID: 17259468
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The metabolic syndrome and its cardiovascular manifestations.
    Sánchez-Torres RJ; Delgado-Osorio H
    Bol Asoc Med P R; 2005; 97(4):271-80. PubMed ID: 16599068
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of the metabolic syndrome insulin resistance and the atherosclerotic diseases in Africans infected by Helicobacter pylori infection and treated by antibiotics.
    Longo-Mbenza B; Nkondi Nsenga J; Vangu Ngoma D
    Int J Cardiol; 2007 Oct; 121(3):229-38. PubMed ID: 17368586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The insulin sensitivity concept].
    Scheen AJ
    Diabetes Metab; 2001 Apr; 27(2 Pt 2):193-200. PubMed ID: 11452210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type II diabetes and syndrome X. Pathogenesis and glycemic management.
    Karam JH
    Endocrinol Metab Clin North Am; 1992 Jun; 21(2):329-50. PubMed ID: 1612069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical implications of insulin resistance.
    Peters AL
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S668-74; discussion S675-81. PubMed ID: 11183420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glucose metabolism in patients with essential hypertension.
    García-Puig J; Ruilope LM; Luque M; Fernández J; Ortega R; Dal-Ré R;
    Am J Med; 2006 Apr; 119(4):318-26. PubMed ID: 16564774
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Genetic predisposition for multiple metabolic syndrome. Part 1. Diabetes mellitus type 2--incidence and prevalence].
    Sobra J
    Cas Lek Cesk; 1999 Jan; 138(1):6-11. PubMed ID: 10953428
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective role of pravastatin in the pathogenesis of the metabolic syndrome.
    Yamagishi S; Matsui T; Sato T; Takeuchi M
    Med Hypotheses; 2006; 66(3):609-11. PubMed ID: 16171951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Insulin resistance in patients with polycystic ovary syndrome.
    Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
    Ann Med; 2004; 36(6):426-39. PubMed ID: 15513294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Insulin resistance and cardiovascular complications].
    Janka HU
    Wien Klin Wochenschr; 1994; 106(24):758-62. PubMed ID: 7846894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detecting insulin resistance in polycystic ovary syndrome: purposes and pitfalls.
    Legro RS; Castracane VD; Kauffman RP
    Obstet Gynecol Surv; 2004 Feb; 59(2):141-54. PubMed ID: 14752302
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Assessment of selected markers of inflammation in patients with clinical symptoms of insulin resistance and normal renal function].
    Bogdański P; Pupek-Musialik D; Luczak M; Szulińska M
    Pol Merkur Lekarski; 2006 Aug; 21(122):165-8; discussion 169. PubMed ID: 17144103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.